What are the typical serum total protein level and albumin-to-globulin (A/G) ratio in multiple myeloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Serum Total Protein and Albumin-to-Globulin Ratio in Multiple Myeloma

In multiple myeloma, total protein is typically elevated (often >8 g/dL, with 30% of patients showing hyperproteinemia), while the albumin-to-globulin (A/G) ratio is characteristically low (reversed), with 54% of patients presenting with a low A/G ratio at diagnosis. 1

Total Protein Findings

  • Hyperproteinemia occurs in approximately 30% of newly diagnosed multiple myeloma patients, reflecting the overproduction of monoclonal immunoglobulins by malignant plasma cells 1

  • The elevated total protein results from increased globulin fraction (specifically the monoclonal protein), while albumin levels are typically normal or decreased 1

  • Serum protein electrophoresis reveals a localized M-band in 70.8% of patients, with 78% migrating to the γ-region and 18% to the β-region 1

Albumin-to-Globulin Ratio Characteristics

  • The A/G ratio is reversed (low) in 54.2% of multiple myeloma patients at diagnosis, making it a valuable diagnostic marker 1

  • The A/G ratio demonstrates high diagnostic accuracy with an AUC of 0.910 for diagnosing multiple myeloma, showing the highest sensitivity among protein markers 2

  • An optimal cutoff of AGR ≤1.16 identifies patients with worse prognosis, as low AGR independently predicts inferior overall survival (HR=1.82) and progression-free survival (HR=1.53) 3

Clinical Significance and Diagnostic Value

  • The reversed A/G ratio results from two mechanisms: decreased albumin production (related to tumor burden and disease stage) and increased globulin from monoclonal protein production 4

  • Hypoalbuminemia correlates significantly with disease stage, tumor burden, and monoclonal IgG levels, with albumin ≤29 g/L identifying advanced disease and virtually all stage III patients having albumin ≤37 g/L 4

  • The A/G ratio effectively differentiates multiple myeloma from other conditions causing protein abnormalities, with AUC of 0.884 for distinguishing MM from liver disease and 0.905 for distinguishing MM from kidney disease 2

Important Caveats

  • Light chain multiple myeloma patients may present with normal A/G ratio despite having elevated α2-globulin concentration, as light chains are not adequately captured by standard protein electrophoresis 1

  • Approximately 4% of patients have non-secretory myeloma where standard protein measurements may be normal, requiring serum free light chain assays for diagnosis 1

  • The presence of anemia, high ESR, and low A/G ratio in elderly patients should prompt immediate investigation for multiple myeloma, as these findings together are highly suggestive of the disease 1

  • Both serum protein electrophoresis and nephelometric quantification should be performed, as they are complementary tests recommended by the International Myeloma Workshop 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.